The world’s first China-developed bone adhesive Bone 02 has earned dual recognition from China’s NMPA Innovative Medical Device pathway and U.S. FDA Breakthrough Device Designation. This revolutionary biomaterial bonds broken bones in wet, bloody conditions and gradually degrades as new bone forms, replacing traditional metal screws with less trauma and faster healing. With over 150 patients in clinical trials, it has shown excellent results in fracture repair, spinal fusion

On May 22, 75-year-old Mr. Qiu from Zhejiang successfully underwent a groundbreaking procedure at Shanghai BDG Brain Hospital: China’s first implantation of a deep brain stimulation (DBS) system using an 8-contact electrode paired with the new G108R brain pacemaker. This marks another major breakthrough in personalized Parkinson’s treatment at our hospital.